Table 2.
Scaled relative importance (RI) scores for each attribute’s influence on choice of multipurpose prevention technology (MPT) design; most important attribute assigned score of 10, and other attributes rescaled relative to most important
| MPT attribute | Uganda | |||||
|---|---|---|---|---|---|---|
| Women | Men | Couple | ||||
| RI | 95% CI | RI | 95% CI | RI | 95% CI | |
| Dosage by form | 10.0 | (6.3, 13.7) | 10.0 | (6.9, 13.1) | 10.0 | (6.0, 14.0) |
| Menstrual bleeding | 4.1 | (2.6, 5.5) | 4.2 | (3.0, 5.3) | 4.7 | (3.2, 6.3) |
| Stomach cramps/nausea | 4.3 | (3.1, 5.6) | 5.4 | (4.0, 6.7) | 5.0 | (3.5, 6.5) |
| Return to fertility | 1.3 | (− 0.3, 2.9) | 1.9 | (0.4, 3.3) | 0.4 | (− 1.0, 1.7) |
| Vaginal environment | 7.6 | (5.5, 9.6) | 6.7 | (5.0, 8.3) | 9.1 | (6.7, 11.4) |
| MPT attribute | Zimbabwe | |||||
|---|---|---|---|---|---|---|
| Women | Men | Couple | ||||
| RI | 95% CI | RI | 95% CI | RI | 95% CI | |
| Dosage by form | 10.0 | (5.3, 14.7) | 10.0 | (5.1, 14.9) | 10.0 | (5.8, 14.2) |
| Menstrual bleeding | 7.2 | (5.1, 9.3) | 7.3 | (5.1, 9.5) | 7.1 | (5.2, 9.0) |
| Stomach cramps/nausea | 7.4 | (5.6, 9.1) | 8.7 | (6.5, 10.9) | 8.0 | (6.2, 9.9) |
| Return to fertility | 4.1 | (2.0, 6.2) | 1.5 | (− 0.8, 3.9) | 1.6 | (− 0.5, 3.6) |
| Vaginal environment | 6.1 | (4.1, 8.2) | 6.5 | (4.2, 8.8) | 5.1 | (3.2, 7.0) |